Accuracy of an automated knowledge base for identifying drug adverse reactions

被引:62
|
作者
Voss, E. A. [1 ,2 ,3 ]
Boyce, R. D. [3 ,4 ]
Ryan, P. B. [1 ,3 ,5 ]
van der Lei, J. [2 ,3 ]
Rijnbeek, P. R. [2 ,3 ]
Schuemie, M. J. [1 ,3 ]
机构
[1] Janssen Res & Dev LLC, Epidemiol Analyt, Raritan, NJ USA
[2] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
[3] OHDSI, New York, NY USA
[4] Univ Pittsburgh, Pittsburgh, PA USA
[5] Columbia Univ, New York, NY USA
关键词
Pharmacovigilance; Adverse drug reaction; Machine-learning experiment; Knowledge base; Health outcome; SIGNAL-DETECTION; HOSPITALIZED-PATIENTS; GOLD STANDARD; OUTCOMES; EVENTS; SAFETY; DESIGN;
D O I
10.1016/j.jbi.2016.12.005
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Introduction: Drug safety researchers seek to know the degree of certainty with which a particular drug is associated with an adverse drug reaction. There are different sources of information used in pharma-covigilance to identify, evaluate, and disseminate medical product safety evidence including spontaneous reports, published peer-reviewed literature, and product labels. Automated data processing and classification using these evidence sources can greatly reduce the manual curation currently required to develop reference sets of positive and negative controls(i.e. drugs that cause adverse drug events and those that do not) to be used in drug safety research. Methods: In this paper we explore a method for automatically aggregating disparate sources of information together into a single repository, developing a predictive model to classify drug-adverse event relationships, and applying those predictions to a real world problem of identifying negative controls for statistical method calibration. Results: Our results showed high predictive accuracy for the models combining all available evidence, with an area under the receiver-operator curve of when tested on three manually generated lists of drugs and conditions that are known to either have or not have an association with an adverse drug event. Conclusions: Results from a pilot implementation of the method suggests that it is feasible to develop a scalable alternative to the time-and-resource-intensive, manual curation exercise previously applied to develop reference sets of positive and negative controls to be used in drug safety research. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:72 / 81
页数:10
相关论文
共 50 条
  • [31] A cross-sectional survey of knowledge, attitude, and willingness to engage in spontaneous reporting of adverse drug reactions by Korean consumers
    Kim, Seungyeon
    Yu, Yun Mi
    You, Myoungsoon
    Jeong, Kyeong Hye
    Lee, Euni
    BMC PUBLIC HEALTH, 2020, 20 (01)
  • [32] Ranking Adverse Drug Reactions With Crowdsourcing
    Gottlieb, Assaf
    Hoehndorf, Robert
    Dumontier, Michel
    Altman, Russ B.
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2015, 17 (03)
  • [33] Adverse Drug Reactions: Part II
    Wooten, James M.
    SOUTHERN MEDICAL JOURNAL, 2010, 103 (11) : 1138 - 1145
  • [34] Identifying adverse drug reactions from free-text electronic hospital health record notes
    Wasylewicz, Arthur
    van de Burgt, Britt
    Weterings, Aniek
    Jessurun, Naomi
    Korsten, Erik
    Egberts, Toine
    Bouwman, Arthur
    Kerskes, Marieke
    Grouls, Rene
    van der Linden, Carolien
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (03) : 1235 - 1245
  • [35] Research Progress on Mechanism and Management of Adverse Drug Reactions of Anlotinib
    Li, Shiting
    Wang, Hongqin
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2023, 17 : 3429 - 3437
  • [36] Adverse drug reactions and prescription errors: morbi-mortality
    Chaio, Sebastian
    Toibaro, Javier
    Valicenti, Pedro
    Saidon, Patricia
    MEDICINA-BUENOS AIRES, 2013, 73 (02) : 111 - 118
  • [37] Frequent Adverse Drug Reactions, and Medication Groups under Suspicion
    Dubrall, Diana
    Schmid, Matthias
    Alesik, Eva
    Paeschke, Norbert
    Stingl, Julia
    Sachs, Bernhardt
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2018, 115 (23): : 393 - +
  • [38] Empirical Bayes Model to Combine Signals of Adverse Drug Reactions
    Harpaz, Rave
    DuMouchel, William
    LePendu, Paea
    Shah, Nigam H.
    19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), 2013, : 1339 - 1347
  • [39] Comparison of different methods for causality assessment of adverse drug reactions
    Behera, Sapan Kumar
    Das, Saibal
    Xavier, Alphienes Stanley
    Velupula, Srinivas
    Sandhiya, Selvarajan
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (04) : 903 - 910
  • [40] A prospective analysis of the preventability of adverse drug reactions reported in Sweden
    Lovborg, Henrik
    Eriksson, Linda Ring
    Jonsson, Anna K.
    Bradley, Thomas
    Hagg, Staffan
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (08) : 1183 - 1189